N/A
N=446
The ACTIVE Intervention to Improve Hospice Care
Pain
Bottom Line
View on ClinicalTrials.gov: NCT01211340 ↗Enrolled (actual)
446
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Caregiver Perceptions of Pain Medicine Questionaire — 49.6; 49; 50.3; 50.5 units on a scale — p=.18
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ACTIVE (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- Female
- Sponsor
- Washington University School of Medicine
- Primary completion
- Apr 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Caregiver Perceptions of Pain Medicine Questionaire |
49.6; 49; 50.3; 50.5 | .18 |
| SECONDARY Caregiver Quality of Life-Revised Subscale Emotional |
7.06; 7.61; 6.95; 7.19 | .15 |
| SECONDARY Anxiety |
6.65; 5.86; 6.37; 5.86 | .89 |
Summary
The ACTIVE Intervention to Improve Hospice Caregiver Pain Management The major goal of this project is to implement and test this promising intervention in three hospice programs. The mixed methods evaluation of this randomized controlled trial (RCT) will provide evidence-based data for a tested intervention manual that hospice staff members can use to integrate the intervention into their practices.
Eligibility Criteria
Inclusion Criteria: Informal Caregiver Inclusion Criteria
- Informal caregiver of an enrolled hospice patient
- Age 18 or over and legally able to provide informed consent
- Involved in decisions related to pain medications
- Access to at least one of the below:
- A standard land line telephone
- A high-speed Internet connection with operational computer
- Without functional hearing loss or with a hearing aid that allows the participant to conduct phone or Internet conversations as assessed by the research staff (by questioning and observation
-
Exclusion Criteria:Informal caregivers of hospice patients with a life expectancy less than 14 days as assessed by the hospice nurse with the palliative performance scale (PPS) (99)
-
Data sourced from ClinicalTrials.gov (NCT01211340). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.